ATE484294T1 - Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen - Google Patents

Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen

Info

Publication number: ATE484294T1
Authority: AT; Austria
Prior art keywords: interleukin; antibodies; treatment; receptor; bronchial hyperresponsiveness
Prior art date: 1995-08-24

Application number

AT05009688T

Other languages

English (en)

Inventor

W Lee Maloy

Prasad U Kari

Nicholas Nicolaides

Original Assignee

Genaera Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-24

Filing date

1996-08-23

Publication date

2010-10-15

1996-08-23 Application filed by Genaera Corp filed Critical Genaera Corp

2010-10-15 Application granted granted Critical

2010-10-15 Publication of ATE484294T1 publication Critical patent/ATE484294T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5425—IL-9
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Cell Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

AT05009688T 1995-08-24 1996-08-23 Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen ATE484294T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US276595P	1995-08-24	1995-08-24
US2380096P	1996-08-06	1996-08-06

Publications (1)

Publication Number	Publication Date
ATE484294T1 true ATE484294T1 (de)	2010-10-15

Family

ID=26670837

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT05009688T ATE484294T1 (de)	1995-08-24	1996-08-23	Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
AT96929657T ATE307203T1 (de)	1995-08-24	1996-08-23	Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT96929657T ATE307203T1 (de)	1995-08-24	1996-08-23	Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma

Country Status (10)

Country	Link
EP (3)	EP1632248B8 (de)
JP (3)	JP3948495B2 (de)
AT (2)	ATE484294T1 (de)
AU (1)	AU6895696A (de)
CA (2)	CA2230240C (de)
DE (2)	DE69638281D1 (de)
DK (2)	DK1632248T3 (de)
ES (2)	ES2249786T3 (de)
PT (1)	PT1632248E (de)
WO (1)	WO1997008321A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5830454A (en) *	1996-08-30	1998-11-03	Ludwig Institute For Cancer Research	Method for treating cell mediated autoimmune disorders using interleukin-9
ATE471982T1 (de) *	1996-12-02	2010-07-15	Genaera Corp	Biologische variabilität von asthma-assoziiertem faktor 2 aaf2 (il-9 rezeptor) nützlich für die behandlung und diagnose von atopischen allergien wie asthma und asthma-ähnlichen erkrankungen
CA2689842A1 (en) *	1996-12-02	1998-06-11	Genaera Corporation	Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
WO1998027997A1 (en) *	1996-12-20	1998-07-02	Magainin Pharmaceuticals Inc.	A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis
WO1999014242A2 (en) *	1997-09-19	1999-03-25	Magainin Pharmaceuticals Inc.	Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
WO1999015656A2 (en) *	1997-09-19	1999-04-01	Magainin Pharmaceuticals Inc.	Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
CA2370821A1 (en) *	1999-05-01	2000-11-09	Genaera Corporation	Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US20010034062A1 (en) *	2000-02-09	2001-10-25	Scott Koenig	Antibody gene therapy with adeno-associated viral vectors
US7094892B2 (en) *	2001-02-22	2006-08-22	The Research Foundation Of State University Of New York	Nucleic acids encoding opiate receptors
EP1401497B1 (de) *	2001-06-08	2012-01-11	Genaera Corporation	Verfahren zur modulation von il-13
WO2004091519A2 (en) *	2003-04-11	2004-10-28	Medimmune, Inc.	Methods of preventing or treating respiratory conditions
US7470521B2 (en)	2004-07-20	2008-12-30	Critical Therapeutics, Inc.	RAGE protein derivatives
US7635754B2 (en) *	2004-09-22	2009-12-22	Aerovance, Inc.	Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
WO2006138429A2 (en)	2005-06-16	2006-12-28	The Feinstein Institute For Medical Research	Antibodies against hmgb1 and fragments thereof
US8133859B2 (en)	2006-09-27	2012-03-13	The United States Of America As Represented By The Department Of Health And Human Services	SCGB3A2 as a growth factor and anti-apoptotic agent
JP5564167B2 (ja) *	2008-05-22	2014-07-30	日本たばこ産業株式会社	苦味マスキング剤及び苦味低減方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5208218A (en) *	1988-09-19	1993-05-04	Ludwig Institute For Cancer Research	T cell growth factor glycoproteins
US5414071A (en)	1989-05-23	1995-05-09	Genetics Institute, Inc.	Human cytokine IL-9
US5132109A (en) *	1990-10-05	1992-07-21	Ludwig Institute For Cancer Research	Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof
AU2237395A (en)	1994-03-30	1995-10-23	University Of Maryland At Baltimore	Human interleukin variants generated by alternative splicing

1996
- 1996-08-23 EP EP05009688A patent/EP1632248B8/de not_active Expired - Lifetime
- 1996-08-23 DE DE69638281T patent/DE69638281D1/de not_active Expired - Lifetime
- 1996-08-23 ES ES96929657T patent/ES2249786T3/es not_active Expired - Lifetime
- 1996-08-23 DK DK05009688.2T patent/DK1632248T3/da active
- 1996-08-23 CA CA002230240A patent/CA2230240C/en not_active Expired - Lifetime
- 1996-08-23 WO PCT/US1996/012757 patent/WO1997008321A1/en active IP Right Grant
- 1996-08-23 JP JP51028397A patent/JP3948495B2/ja not_active Expired - Fee Related
- 1996-08-23 PT PT05009688T patent/PT1632248E/pt unknown
- 1996-08-23 ES ES05009688T patent/ES2354360T3/es not_active Expired - Lifetime
- 1996-08-23 EP EP10004496A patent/EP2241329A3/de not_active Withdrawn
- 1996-08-23 EP EP96929657A patent/EP0846173B1/de not_active Expired - Lifetime
- 1996-08-23 DK DK96929657T patent/DK0846173T3/da active
- 1996-08-23 AT AT05009688T patent/ATE484294T1/de active
- 1996-08-23 DE DE69635305T patent/DE69635305T2/de not_active Expired - Lifetime
- 1996-08-23 AU AU68956/96A patent/AU6895696A/en not_active Abandoned
- 1996-08-23 CA CA002666298A patent/CA2666298A1/en not_active Abandoned
- 1996-08-23 AT AT96929657T patent/ATE307203T1/de active
2007
- 2007-01-09 JP JP2007001870A patent/JP4813380B2/ja not_active Expired - Fee Related
2011
- 2011-02-28 JP JP2011043283A patent/JP2011152135A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
ATE307203T1 (de)	2005-11-15
DE69635305T2 (de)	2006-07-06
WO1997008321A1 (en)	1997-03-06
JP4813380B2 (ja)	2011-11-09
JP2011152135A (ja)	2011-08-11
EP0846173B1 (de)	2005-10-19
PT1632248E (pt)	2010-12-28
EP1632248B8 (de)	2010-12-29
EP1632248A1 (de)	2006-03-08
EP1632248B1 (de)	2010-10-13
DE69638281D1 (de)	2010-11-25
EP2241329A3 (de)	2011-03-09
JP3948495B2 (ja)	2007-07-25
CA2230240C (en)	2009-08-18
ES2354360T3 (es)	2011-03-14
DK0846173T3 (da)	2006-01-16
CA2666298A1 (en)	1997-03-06
ES2249786T3 (es)	2006-04-01
DE69635305D1 (de)	2006-03-02
EP0846173A1 (de)	1998-06-10
CA2230240A1 (en)	1997-03-06
JP2007169287A (ja)	2007-07-05
AU6895696A (en)	1997-03-19
DK1632248T3 (da)	2011-01-24
JPH11514851A (ja)	1999-12-21
EP2241329A2 (de)	2010-10-20

Publication	Publication Date	Title
ATE484294T1 (de)	2010-10-15	Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
ATA76995A (de)	2002-04-15	Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69124293D1 (de)	1997-03-06	Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE69609868D1 (de)	2000-09-21	Neue steroidester zur behandlung von hauterkrankungen
DE3869490D1 (de)	1992-04-30	Verfahren zur elektrochemischen behandlung von stoffen.
DE3772429D1 (de)	1991-10-02	Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE10199020I2 (de)	2004-05-06	Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69022249D1 (de)	1995-10-12	Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE3687069D1 (de)	1992-12-10	Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE69616376D1 (de)	2001-11-29	Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69526437D1 (de)	2002-05-23	Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
DE3882775D1 (de)	1993-09-09	Zusammensetzung zur behandlung von parodontaler krankheit.
ATA902789A (de)	1995-07-15	Verfahren zur katalytischen behandlung von abwasser
DE69004189D1 (de)	1993-12-02	Anordnungen zur behandlung menschlichen oder tierischen abfalls mittels mikrowellen.
ATE213163T1 (de)	2002-02-15	Verfahren zur behandlung von motorischen defiziten
DE69607559D1 (de)	2000-05-11	Verfahren zur Behandlung von Phenolteer
ATE179594T1 (de)	1999-05-15	Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
DE3875016D1 (de)	1992-11-05	Therapeutikum zur behandlung von aids.
DE69111324D1 (de)	1995-08-24	Vorrichtung zur Behandlung oder Trennung von Gasen.
DE68903208D1 (de)	1992-11-19	Verfahren zur thermischen behandlung von laktoferrin.
DE68913995D1 (de)	1994-04-21	Zusammensetzung zur behandlung progressiver myopie.
DE3886755D1 (de)	1994-02-10	Verfahren zur behandlung von gefässkrankheiten.
DE69006509D1 (de)	1994-03-17	Verfahren zur behandlung von häuten.
DE69734349D1 (de)	2006-02-23	Behandlung von knochenleiden mit adrenomedullin
DE68903930D1 (de)	1993-01-28	Lipidemulsion zur behandlung von aids.

Legal Events

Date	Code	Title	Description
2011-09-15	UEP	Publication of translation of european patent specification	Ref document number: 1632248 Country of ref document: EP

Date

Code

Title

Description

2011-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1632248

Country of ref document: EP